1. Home
  2. WHLRD vs YDESW Comparison

WHLRD vs YDESW Comparison

Compare WHLRD & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheeler Real Estate Investment Trust Inc.

WHLRD

Wheeler Real Estate Investment Trust Inc.

HOLD

Current Price

$38.31

Market Cap

0.0

Sector

Real Estate

ML Signal

HOLD

YDESW

YD Bio Limited Warrants

HOLD

Current Price

$0.24

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHLRD
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
49
15
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WHLRD
YDESW
Price
$38.31
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
909.0
8.7K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.25
$0.20
52 Week High
$42.00
$2.85

Technical Indicators

Market Signals
Indicator
WHLRD
YDESW
Relative Strength Index (RSI) 54.47 37.40
Support Level $38.00 N/A
Resistance Level $39.99 $0.36
Average True Range (ATR) 0.68 0.04
MACD 0.18 0.00
Stochastic Oscillator 82.84 22.12

Price Performance

Historical Comparison
WHLRD
YDESW

About WHLRD Wheeler Real Estate Investment Trust Inc.

Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: